Stéphane Savary

Stéphane Savary

orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 1994 in Genomics
Verified
Journal Article
Closed access
MLMarie Françoise Luciani
Marie Françoise Luciani
FDFrançois Denizot
François Denizot
SSStéphane Savary
Stéphane Savary
MMMarie Geneviève Mattei
Marie Geneviève Mattei
GCGiovanna Chimini
Giovanna Chimini

6 February 1996 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
GLG Lombard-Platet
G Lombard-Platet
SSStéphane Savary
Stéphane Savary
CSC O Sarde
C O Sarde
JMJ L Mandel
J L Mandel
GCG Chimini
G Chimini
Adrenoleukodystrophy (ALD), a severe demyelinating disease, is caused by mutations in a gene coding for a peroxisomal membrane protein (ALDP), which belongs to the superfamily of ATP binding cassette (ABC) transporters and has the structure of a half transporter. ALDP showed 38% sequence identity with another peroxisomal membrane protein, PMP70, up to now its closest homologue. We describe here the cloning and characterization of a mouse ALD-related gene (ALDR), which codes for a protein with 66% identity with ALDP and shares the same half transporter structure. The ALDR protein was overexpressed in COS cells and was found to be associated with the peroxisomes. The ALD and ALDR genes show overlapping but clearly distinct expression patterns in mouse and may thus play similar but nonequivalent roles. The ALDR gene, which appears highly conserved in man, is a candidate for being a modifier gene that could account for some of the extreme phenotypic variability of ALD. The ALDR gene is also a candidate for being implicated in one of the complementation groups of Zellweger syndrome, a genetically heterogeneous disorder of peroxisome biogenesis, rare cases of which were found to be associated with mutations in the PMP70 (PXMP1) gene.

Verified
Journal Article
Open access
PDF file
FCFrancesca Di Cara
Francesca Di Cara
Pierre AndreolettiPierre Andreoletti
Pierre Andreoletti
DTDoriane Trompier
Doriane Trompier
Anne VEJUXAnne VEJUX
Anne VEJUX
MBMargret H. Bülow
Margret H. Bülow
SSStéphane Savary
Stéphane Savary
The immune response is essential to protect organisms from infection and an altered self. An organism’s overall metabolic status is now recognized as an important and long-overlooked mediator of immunity and has spurred new explorations of immune-related metabolic abnormalities. Peroxisomes are essential metabolic organelles with a central role in the synthesis and turnover of complex lipids and reactive species. Peroxisomes have recently been identified as pivotal regulators of immune functions and inflammation in the development and during infection, defining a new branch of immunometabolism. This review summarizes the current evidence that has helped to identify peroxisomes as central regulators of immunity and highlights the peroxisomal proteins and metabolites that have acquired relevance in human pathologies for their link to the development of inflammation, neuropathies, aging and cancer. This review then describes how peroxisomes govern immune signaling strategies such as phagocytosis and cytokine production and their relevance in fighting bacterial and viral infections. The mechanisms by which peroxisomes either control the activation of the immune response or trigger cellular metabolic changes that activate and resolve immune responses are also described.

1 June 2012 in Neuroscience
Verified
Journal Article
Closed access
MBM. Baarine
M. Baarine
Pierre AndreolettiPierre Andreoletti
Pierre Andreoletti
AAA. Athias
A. Athias
TNT. Nury
T. Nury
AZA. Zarrouk
A. Zarrouk
GLG. Lizard
G. Lizard

1 March 2014 in Biochimie
Verified
Journal Article
Closed access
DTDoriane Trompier
Doriane Trompier
AVA. Vejux
A. Vejux
AZA. Zarrouk
A. Zarrouk
CGC. Gondcaille
C. Gondcaille
FGF. Geillon
F. Geillon
Gérard Hubert LizardGérard Hubert Lizard
Gérard Hubert Lizard

1 October 2012 in Current Drug Metabolism
Verified
Journal Article
Closed access
PDF file
SSStéphane Savary
Stéphane Savary
DTDoriane Trompier
Doriane Trompier
Pierre AndreolettiPierre Andreoletti
Pierre Andreoletti
FBFrancoise Le Borgne
Francoise Le Borgne
JDJean Demarquoy
Jean Demarquoy
GLGerard Lizard
Gerard Lizard
Fatty acids are known to serve as energetic substrates, key components of membrane lipids, and as substrates for the synthesis of signaling molecules and complex lipids. They are also known to be ligands either of membrane receptors involved in cell signaling or of nuclear receptors mediating gene regulation. Accumulation of fatty acids due to altered metabolism and/or unbalanced diet has been described to be toxic for several tissues, especially liver. In numerous cell types, cell death, cytokine secretion and activation of inflammatory processes appear to be a consequence of fatty acid accumulation. This review presents the different classes of fatty acids known to trigger toxic effects and inflammation, the cellular and subcellular targets of these fatty acids in the context of non-alcoholic fatty liver disease (NAFLD), and the mechanisms by which these effects are mediated.